Consistent with a role for the Raf–MEK1/2–ERK1/2 module in mammary carcinogenesis, ERK1/2 are activated in primary breast cancer tissue and in associated lymph node metastases [13,14]. The gene discussed is MAP2K1; the disease is breast carcinoma.